Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

The normal human prostate does not significantly affect blood DHT levels.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Anti-androgens are effective for female acne but less so for male-pattern hair loss, with side effects similar to birth control pills.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Gene mutations can cause problems in male genital development.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Trichofolliculoma is a unique benign tumor mainly affecting middle-aged adults' faces, often misdiagnosed without histopathology.

Women with hair loss have more androgen receptors in certain hair follicles.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.